>One of the keys to cutting the cost of drugs in the United States is to raise their cost in other countries, Eli Lilly CEO David Ricks said Tuesday in an [interview](https://www.youtube.com/watch?v=pLOeR8uixyE) at the Economic Club of Washington, D.C.
>Ricks added that accomplishing this goal will be one of the focuses of the incoming administration of President Donald Trump in his efforts surrounding healthcare.
>“We have to raise developed countries, what they pay, and we can lower the U.S.,” Ricks said. “I think that’s a policy argument we’ll hear about soon with the new administration.”
>Last week, Ricks was one of the guests at a dinner hosted by Trump at his Mar-a-Lago residence. The event also included Pfizer CEO Albert Bourla, PhRMA CEO Stephen Ubl, Health and Human Services secretary nominee Robert F. Kennedy Jr. and incoming chief of staff Susie Wiles.
LtCdrHipster on
Someone steelman the argument against this, because honestly it does seem like Europe is free-riding on Americans being overcharged for drugs to cover development costs to subsidize their lower costs.
2 Comments
>One of the keys to cutting the cost of drugs in the United States is to raise their cost in other countries, Eli Lilly CEO David Ricks said Tuesday in an [interview](https://www.youtube.com/watch?v=pLOeR8uixyE) at the Economic Club of Washington, D.C.
>Ricks added that accomplishing this goal will be one of the focuses of the incoming administration of President Donald Trump in his efforts surrounding healthcare.
>“We have to raise developed countries, what they pay, and we can lower the U.S.,” Ricks said. “I think that’s a policy argument we’ll hear about soon with the new administration.”
>Last week, Ricks was one of the guests at a dinner hosted by Trump at his Mar-a-Lago residence. The event also included Pfizer CEO Albert Bourla, PhRMA CEO Stephen Ubl, Health and Human Services secretary nominee Robert F. Kennedy Jr. and incoming chief of staff Susie Wiles.
Someone steelman the argument against this, because honestly it does seem like Europe is free-riding on Americans being overcharged for drugs to cover development costs to subsidize their lower costs.